Renalytix AI (RNLX)
(Real Time Quote from BATS)
$0.34 USD
+0.02 (5.26%)
Updated Aug 26, 2024 01:34 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Income Statements
Fiscal Year end for Renalytix AI PLC Sponsored ADR falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
---|---|---|---|---|---|
Sales | NA | 3 | 3 | 1 | 0 |
Cost Of Goods | NA | 3 | 2 | 1 | 0 |
Gross Profit | NA | 1 | 1 | 1 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 43 | 54 | 33 | 10 |
Income After Depreciation & Amortization | 0 | -42 | -53 | -32 | -10 |
Non-Operating Income | NA | -3 | 8 | -3 | 0 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | -46 | -45 | -35 | -10 |
Income Taxes | NA | 0 | 0 | 0 | 0 |
Minority Interest | NA | 0 | 0 | -1 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -46 | -45 | -35 | -10 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -46 | -45 | -35 | -10 |
Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -42 | -53 | -32 | -10 |
Depreciation & Amortization (Cash Flow) | NA | 1 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 0 | -42 | -53 | -32 | -10 |
Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Average Shares | NA | 82.21 | 72.73 | 71.49 | 59.42 |
Diluted EPS Before Non-Recurring Items | NA | -0.50 | -0.78 | -0.43 | -0.16 |
Diluted Net EPS (GAAP) | NA | -1.10 | -1.23 | -0.97 | -0.34 |
Fiscal Year end for Renalytix AI PLC Sponsored ADR falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.54 | 0.71 | 0.46 | 0.52 |
Cost Of Goods | NA | 0.60 | 0.48 | 0.50 | 0.67 |
Gross Profit | NA | -0.07 | 0.23 | -0.04 | -0.16 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.07 | 8.57 | 8.85 | 9.78 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -6.14 | -8.34 | -8.89 | -9.94 |
Non-Operating Income | NA | -1.61 | -0.15 | -1.27 | -1.17 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -7.74 | -8.48 | -10.15 | -11.10 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -7.74 | -8.49 | -10.15 | -11.10 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -7.74 | -8.49 | -10.15 | -11.10 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 97.66 | 97.27 | 94.77 | 96.99 |
Diluted EPS Before Non-Recurring Items | NA | -0.08 | -0.09 | -0.11 | -0.10 |
Diluted Net EPS (GAAP) | NA | -0.16 | -0.17 | -0.21 | -0.22 |